Integrating machine learning-based molecular design with experimental validation for the discovery of EGFR inhibitors in lung cancer.
Journal: Molecular diversity
•
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
Qie H, Wang L, Li C, et al. (2026). "Integrating machine learning-based molecular design with experimental validation for the discovery of EGFR inhibitors in lung cancer.". Molecular diversity. https://doi.org/10.1007/s11030-026-11625-z